GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Solta Medical Inc (SLTM) [hlAlert]

Rating:
Buy SLTM
down 26.81 %

Thermage, Inc. (SLTM) rated Buy with price target $3.50 by Stanford Research

Posted on: Friday,  Jan 23, 2009  9:25 AM ET by Stanford Research

Stanford Research rated Buy Solta Medical Inc (NASDAQ: SLTM) on 01/23/2009. Previously Stanford Research rated Buy Solta Medical Inc (NASDAQ: SLTM) on
09/19/2008., when the stock price was $3.99. Since then, Solta Medical Inc has lost 26.82% as of 01/22/2014's recent price of $2.92.
If you would have followed the previous Stanford Research's recommendation on SLTM, you would have lost 26.81% of your investment in 1951 days.

Solta Medical Inc., formerly Thermage, Inc. is engaged in designing, developing, manufacturing and marketing energy-based medical device systems for aesthetic applications. These systems are marketed under the brand names Fraxel and Thermage and are Food & Drug Administration (FDA) cleared for dermatological procedures in the applications, which include: Skin Tightening, the Thermage NXT system offers non-invasive treatment options for skin tightening and contouring, body shaping, and improvement in the appearance of cellulite; Skin Rejuvenation, the Fraxel re:fine and Fraxel re:store systems offer treatments for skin conditions such as fine lines and pigmentation.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/23/2009 9:25 AM Buy
None
1.32 3.50
as of 12/31/2009
1 Week up  28.71 %
1 Month up  19.81 %
3 Months up  14.53 %
1 YTD down  -14.75 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/19/2008 8:25 AM Buy
None
3.99 8.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy